Related Experiment Video
Updated: May 24, 2025

Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example
Published on: December 3, 2014
Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia
Lucía Quintana-Castanedo1,2, Rocío Maseda1, Isabel Pérez-Conde1
1Department of Dermatology, Hospital La Paz, Madrid, Spain.
Anemia in Recessive Dystrophic Epidermolysis Bullosa (RDEB) is linked to disease severity and inflammation. Bone marrow response is often inadequate, highlighting the need for targeted anemia management strategies in RDEB.
Area of Science:
- Dermatology
- Hematology
- Genetics
Background:
- Recessive dystrophic epidermolysis bullosa (RDEB) causes severe skin fragility and chronic anemia.
- Anemia in RDEB is complex, multifactorial, and often resistant to standard treatments.
Purpose of the Study:
- To investigate factors contributing to anemia in RDEB patients.
- To analyze hematological parameters, cytokine profiles, and the erythropoietin-erythroferrone-hepcidin axis in RDEB.
- To identify risk factors for anemia in RDEB.
Main Methods:
- Cross-sectional study of a representative RDEB cohort stratified by disease severity, anemia, and iron status.
- Analysis of hematological parameters, cytokine profiles (IL-6, IL-1β, IL-10, TNF, IFN-γ), and the EPO-ERFE-hepcidin axis.
- Assessment of bone marrow response using the reticulocyte production index.
Main Results:
- Anemia was present in 50% of the RDEB cohort.
- Hemoglobin levels negatively correlated with body surface area affected and C-reactive protein (CRP) levels.
- Moderate-to-severe inflammation (CRP ≥ 15 mg/L) was universal in anemic patients, but no specific cytokine profile was consistently linked to anemia risk.
- Inadequate bone marrow response (reticulocyte production index) was observed in 90% of anemic patients.
- Erythroferrone (ERFE) levels were higher in iron deficiency, but showed no consistent correlation with erythropoietin (EPO).
- Elevated hepcidin correlated with high ferritin levels, particularly in patients with a history of iron infusions or transfusions.
Conclusions:
- Disease severity and inflammation are key risk factors for anemia in RDEB.
- The erythropoietin-erythroferrone-hepcidin axis regulation is complex and dysregulated in RDEB anemia.
- Inadequate bone marrow response is a significant contributor to anemia in RDEB.
- Personalized approaches addressing inflammation and iron dysregulation are crucial for effective anemia management in RDEB.
More Related Videos
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
05:08Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Related Concept Videos
Erythropoiesis
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal